======= ADARB1 ======= == Gene Information == * **Official Symbol**: ADARB1 * **Official Name**: adenosine deaminase RNA specific B1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=104|104]] * **UniProt**: [[https://www.uniprot.org/uniprot/P78563|P78563]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ADARB1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ADARB1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601218|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes the enzyme responsible for pre-mRNA editing of the glutamate receptor subunit B by site-specific deamination of adenosines. Studies in rat found that this enzyme acted on its own pre-mRNA molecules to convert an AA dinucleotide to an AI dinucleotide which resulted in a new splice site. Alternative splicing of this gene results in several transcript variants, some of which have been characterized by the presence or absence of an ALU cassette insert and a short or long C-terminal region. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: N/A |A deamin| |dsrm| |hypoglossal nerve morphogenesis| |hypoglossal nerve development| |motor neuron apoptotic process| |spinal cord ventral commissure morphogenesis| |tRNA-specific adenosine deaminase activity| |double-stranded RNA adenosine deaminase activity| |motor behavior| |negative regulation of protein kinase activity by regulation of protein phosphorylation| |adenosine to inosine editing| |facial nerve development| |facial nerve morphogenesis| |neuromuscular process controlling posture| |preganglionic parasympathetic fiber development| |parasympathetic nervous system development| |base conversion or substitution editing| |central nervous system projection neuron axonogenesis| |innervation| |cranial nerve morphogenesis| |neuromuscular synaptic transmission| |central nervous system neuron axonogenesis| |positive regulation of viral genome replication| |neuron apoptotic process| |autonomic nervous system development| |cranial nerve development| |neuron death| |positive regulation of viral life cycle| |double-stranded RNA binding| |nerve development| |muscle tissue morphogenesis| |central nervous system neuron development| |multicellular organism growth| |muscle organ morphogenesis| |regulation of viral genome replication| |spinal cord development| |positive regulation of viral process| |neuromuscular process| |regulation of viral life cycle| |mRNA binding| |RNA modification| |central nervous system neuron differentiation| |defense response to virus| |regulation of viral process| |regulation of symbiosis, encompassing mutualism through parasitism| |negative regulation of protein kinase activity| |negative regulation of kinase activity| |negative regulation of cell migration| |negative regulation of cell motility| |negative regulation of transferase activity| |response to virus| |muscle organ development| |negative regulation of cellular component movement| |negative regulation of locomotion| |axonogenesis| |developmental growth| |growth| |negative regulation of protein phosphorylation| |axon development| |anterograde trans-synaptic signaling| |chemical synaptic transmission| |cell morphogenesis involved in neuron differentiation| |trans-synaptic signaling| |negative regulation of phosphorylation| |synaptic signaling| |muscle structure development| |mRNA processing| |neuron projection morphogenesis| |plasma membrane bounded cell projection morphogenesis| |cell projection morphogenesis| |positive regulation of multi-organism process| |cell part morphogenesis| |cell morphogenesis involved in differentiation| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |tissue morphogenesis| |behavior| |negative regulation of protein modification process| |neuron projection development| |negative regulation of cell population proliferation| |mRNA metabolic process| |cell morphogenesis| |innate immune response| |regulation of multi-organism process| |negative regulation of catalytic activity| |regulation of protein kinase activity| |neuron development| |cellular component morphogenesis| |regulation of cell migration| |nucleolus| |regulation of kinase activity| |RNA processing| |regulation of cell motility| |apoptotic process| |defense response to other organism| |animal organ morphogenesis| |regulation of transferase activity| |central nervous system development| |regulation of locomotion| |regulation of cellular component movement| |neuron differentiation| |negative regulation of cellular protein metabolic process| |programmed cell death| |immune effector process| |cell death| |negative regulation of protein metabolic process| |cell-cell signaling| |plasma membrane bounded cell projection organization| |negative regulation of molecular function| |cell projection organization| |regulation of cell cycle| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |nervous system process| |RNA binding| |regulation of protein phosphorylation| |generation of neurons| |regulation of phosphorylation| |regulation of cell population proliferation| |neurogenesis| |cell development| |RNA metabolic process| |tissue development| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| |immune response| |system process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp156|UNC2400 2μM R03 exp156]]|-1.91| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-1.82| |[[:results:exp239|PFI-2 4μM R05 exp239]]|-1.77| |[[:results:exp517|Quercetin 20μM R08 exp517]]|-1.72| |[[:results:exp528|TGF-beta1 44ng/ml R08 exp528]]|1.79| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|2.34| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18282 * **Expression level (log2 read counts)**: 6.45 {{:chemogenomics:nalm6 dist.png?nolink |}}